NEW YORK (GenomeWeb) – Rosetta Genomics announced today that it has begun collaborating with Israel's Weizmann Institute of Science on the development of new methods for the preparation of next-generation sequencing libraries for small RNAs.

Rosetta will specifically work with the institute's Nancy and Stephen Grand Israel National Center for Personalized Medicine to create computational methods required for data analysis that enable more accurate quantification of microRNAs in different biological samples and under various pathological conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.